- The Wall Street Journal•6 hours ago
An executive who guided venture-backed InnoPharma to a $360 million merger with Pfizer in 2014 has led the fundraising.
- Bloomberg Video•9 hours ago
July 27 -- Dan Deming, KKM Financial's managing director, discusses the performance of stocks and his options strategy for Pfizer with Bloomberg's Julie Hyman on "Bloomberg Markets."
After hours: 36.860.01 (0.03%) as of 7:58 PM EDT
|Bid||36.85 x 100|
|Ask||36.86 x 100|
|52wk Range||28.25 - 37.19|
|Day's Range||36.65 - 36.92|
|Avg Vol (3m)||24,866,500|
As of 4:00 PM EDT. Market closed.